Shorla Oncology Shorla Oncology (also known as Shorla Pharma) is a pharmaceutical company that develops cancer treatment solutions. | ![]() BioNTech BioNTech is a biotechnology company developing immunotherapies for cancer and infectious diseases. | ![]() Emtora Biosciences Emtora Biosciences is a life science company developing eRap, a formulation of rapamycin for the prevention of cancer progression/recurrence. | ![]() OS Therapies OS Therapies (OST) is a therapeutic company focused on identifying, developing, and commercializing treatments for osteosarcoma. | ||
Founding Date | Founding Date 2014 | Founding Date 2018 | Founding Date 2008 | Founding Date N/A | Founding Date 2018 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Södertälje, SE HQ | Locations Clonmel, IE HQ Cambridge, US | Locations San Antonio, US HQ | Locations Rockville, US HQ | |
Employees | Employees 3 | Employees 4914% increase | Employees 6,772 | Employees 2 | Employees 4 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 27.1 b | Valuation ($) N/A | Valuation ($) 55.5 m |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income (€1.1b) (FY, 2025) | Net income N/A | Net income ($28.8m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 35m (over 2 years ago) | Latest funding round N/A | Latest funding round $ 3m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 43.3m | Total funding raised N/A | Total funding raised $ 3m | Total funding raised $ 6m |
Shorla Oncology (also known as Shorla Pharma) is a pharmaceutical company that develops cancer treatment solutions.
View company
BioNTech is a biotechnology company developing immunotherapies for cancer and infectious diseases.
View company
Emtora Biosciences is a life science company developing eRap, a formulation of rapamycin for the prevention of cancer progression/recurrence.
View company
OS Therapies (OST) is a therapeutic company focused on identifying, developing, and commercializing treatments for osteosarcoma.
View company